• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 9.2: In-Stent Restenosis After Bare Metal and Drug-Eluting Stents

    Roxana Mehran, MD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour

    Faculty Disclosure

    Nothing to Disclose

    Learning Objectives

    • Discuss the mechanisms and patterns of in-stent restenosis
    • Understand the treatment of in-stent restenosis and its limitations
    • Discuss the use of drug-eluting stents in the treatment of in-stent restenosis especially in comparison to previous techniques
    • Understand the impact of drug-eluting stents on the frequency and patterns of in-stent restenosis